122 related articles for article (PubMed ID: 3932173)
1. Serum pepsin activity as a parameter of gastric acid secretion.
Massarrat S
Hepatogastroenterology; 1985 Aug; 32(4):185-90. PubMed ID: 3932173
[TBL] [Abstract][Full Text] [Related]
2. Changes in total pepsin activity and pepsinogen I in human sera under stimulation and inhibition of gastric acid secretion.
Schumann KM; Massarrat S
Hepatogastroenterology; 1991 Dec; 38 Suppl 1():33-6. PubMed ID: 1823064
[TBL] [Abstract][Full Text] [Related]
3. Serum pepsinogen I levels: assessment of gastric acid secretion?
Goedhard JG; Biemond I; Giliams JP; Pals G; Kreuning J
Prog Clin Biol Res; 1985; 173():139-46. PubMed ID: 3983192
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of pepsinogen secretion: influence of pentagastrin on pepsinogen secretion in man.
Ten Kate RW; Tuynman HA; Festen HP; Pals G; Meuwissen SG
Hepatogastroenterology; 1990 Feb; 37(1):124-7. PubMed ID: 2107135
[TBL] [Abstract][Full Text] [Related]
5. The effects of impromidine and pentagastrin on gastric output of histamine, acid and pepsin in man.
Peden NR; Boyd EJ; Callachan H; Shepherd DM; Wormsley KG
Hepatogastroenterology; 1982 Feb; 29(1):30-4. PubMed ID: 6212525
[TBL] [Abstract][Full Text] [Related]
6. Effect of high dose omeprazole on gastric pepsin secretion and serum pepsinogen levels in man.
Ten Kate RW; Tuynman HA; Festen HP; Pals G; Meuwissen SG
Eur J Clin Pharmacol; 1988; 35(2):173-6. PubMed ID: 3142776
[TBL] [Abstract][Full Text] [Related]
7. [The acidity and peptic activity of gastric juice in healthy children and in children suffering from cystic fibrosis (author's transl)].
Fieber M; Meschede R; Tolckmitt W
Z Kinderheilkd; 1975 Sep; 120(3):199-209. PubMed ID: 241164
[TBL] [Abstract][Full Text] [Related]
8. Esaprazole effect on acid, peptic and alkaline secretion in duodenal ulcer patients.
Dal Santo PL; Vianello F; Germana B; Dotto P; Laino G; Del Bianco T; Plebani M; Leandro G; Savarino V; Di Mario F
Z Gastroenterol; 1993 Jan; 31(1):11-4. PubMed ID: 8447149
[TBL] [Abstract][Full Text] [Related]
9. Effects of Helicobacter pylori on gastritis, pentagastrin-stimulated gastric acid secretion, and meal-stimulated plasma gastrin release in the absence of peptic ulcer disease.
Hurlimann S; Dür S; Schwab P; Varga L; Mazzucchelli L; Brand R; Halter F
Am J Gastroenterol; 1998 Aug; 93(8):1277-85. PubMed ID: 9707051
[TBL] [Abstract][Full Text] [Related]
10. Serum group I pepsinogens and gastrin in relation to gastric H+ and pepsin outputs before and after subcutaneous injection of pentagastrin.
Waldum HL; Burhol PG; Straume BK
Scand J Gastroenterol; 1978; 13(8):943-6. PubMed ID: 31675
[TBL] [Abstract][Full Text] [Related]
11. A study of the relationship between serum group I pepsinogen levels and gastric acid secretion.
Samloff IM; Secrist DM; Passaro E
Gastroenterology; 1975 Dec; 69(6):1196-200. PubMed ID: 1193320
[TBL] [Abstract][Full Text] [Related]
12. Antisecretory agents, peptic secretion and serum pepsinogen in man.
Dobrilla G; Amplatz S; Benvenuti S; Comberlato M; Martini G
Ital J Gastroenterol; 1991 Feb; 23(2):100-6. PubMed ID: 1684121
[TBL] [Abstract][Full Text] [Related]
13. The effects of chronic consumption of heroin on basal and vagal electrical-stimulated gastric acid and pepsin secretion in rat.
Rafsanjani FN; Maghouli F; Vahedian J; Esmaeili F
Saudi Med J; 2004 Oct; 25(10):1356-9. PubMed ID: 15494801
[TBL] [Abstract][Full Text] [Related]
14. Method for determining serum pepsinogen concentration, using pepsin standards and ultraviolet absorbance.
Harvey-White JD; Allen EH
Am J Vet Res; 1982 Jul; 43(7):1317-20. PubMed ID: 6808872
[TBL] [Abstract][Full Text] [Related]
15. Serum group I pepsinogens after consecutive stimulations with insulin and pentagastrin in unoperated duodenal ulcer patients and in duodenal ulcer patients after proximal gastric vagotomy.
Paimela H; Lalla M; Räsänen V
Scand J Gastroenterol; 1984 Jan; 19(1):52-5. PubMed ID: 6369521
[TBL] [Abstract][Full Text] [Related]
16. Effect of betazole on serum group I pepsinogen levels: relationship to gastric acid output in unoperated and postoperative patients.
Samloff IM; Secrist DM; Passaro E
Gastroenterology; 1977 May; 72(5 Pt 1):845-8. PubMed ID: 849814
[TBL] [Abstract][Full Text] [Related]
17. Pepsins, peptic activity, and peptic inhibitors.
Samloff IM
J Clin Gastroenterol; 1981; 3(Suppl 2):91-4. PubMed ID: 6119339
[TBL] [Abstract][Full Text] [Related]
18. Influence of intravenous pirenzepine on gastric acid and pepsin in man.
el-Sabbagh HN; Prinz RA; Welbourn RB; Baron JH
Scand J Gastroenterol Suppl; 1980; 66():73-7. PubMed ID: 6787694
[TBL] [Abstract][Full Text] [Related]
19. Salivary and gastric epidermal growth factor in patients with Zollinger-Ellison syndrome: its protective potential.
Sarosiek J; Jensen RT; Maton PN; Peura DA; Harlow D; Feng T; McCallum RW; Pisegna JR
Am J Gastroenterol; 2000 May; 95(5):1158-65. PubMed ID: 10811321
[TBL] [Abstract][Full Text] [Related]
20. Apparent and intrinsic sensitivity to pentagastrin of acid and pepsin secretion in peptic ulcer.
Hirschowitz BI
Gastroenterology; 1984 May; 86(5 Pt 1):843-51. PubMed ID: 6423436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
